The healthcare sector has been underperforming in recent years, but there are still plenty of attractive healthcare stocks that investors should consider for long-term growth. Two such candidates are Intuitive Surgical (NASDAQ: ISRG) and Vertex Pharmaceuticals (NASDAQ: VRTX).
Intuitive Surgical has faced challenges in the past year, including high tariffs impacting its financial results and increased competition in the robotic-assisted surgery (RAS) market. Despite these obstacles, the company remains a leader in the RAS market and develops cutting-edge robot surgery devices like the da Vinci system. With an underpenetrated market and a strong competitive advantage, Intuitive Surgical is well-positioned for long-term success. Its installed base is growing, leading to increased procedure volume and steady growth.
Vertex Pharmaceuticals, known for its success in treating cystic fibrosis, is now expanding into new therapeutic areas. The company plans to submit regulatory applications for zimislecel, a therapy for type 1 diabetes, and has important late-stage data readouts for other potential medicines. With a diverse product lineup and ongoing growth in its core CF franchise, Vertex Pharmaceuticals is poised for further success.
Before investing in Intuitive Surgical, it’s important to consider other top healthcare stocks identified by the Motley Fool Stock Advisor team. These stocks have the potential to generate significant returns in the coming years, as evidenced by past recommendations like Netflix and Nvidia.
In conclusion, both Intuitive Surgical and Vertex Pharmaceuticals offer strong growth potential for investors looking to build a diversified healthcare portfolio. By staying informed about industry trends and top stock picks, investors can make informed decisions about their long-term investment strategies.
